Announcement

Collapse
No announcement yet.

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada

    Emerg Infect Dis. 2019 Apr;25(4):838-840. doi: 10.3201/eid2504.181554.
    Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.

    Abed Y, Fage C, Lag?e P, Carbonneau J, Papenburg J, Vinh DC, Boivin G.
    Abstract

    We identified an influenza B isolate harboring a Gly407Ser neuraminidase substitution in an immunocompromised patient in Canada before antiviral therapy. This mutation mediated reduced susceptibility to oseltamivir, zanamivir, and peramivir, most likely by preventing interaction with the catalytic Arg374 residue. The potential emergence of such variants emphasizes the need for new antivirals.


    KEYWORDS:

    Canada; Gly407Ser; influenza; influenza B; neuraminidase; oseltamivir; peramivir; resistance; viruses; zanamivir

    PMID: 30882323 DOI: 10.3201/eid2504.181554
    Free full text







    Detect languageundefined undefined




    Text-to-speech function is limited to 200 characters



Working...
X